"Designing Growth Strategies is in our DNA"

Inflammatory Bowel Disease Treatment Market Size, Share & Industry Analysis, By Disease Indication (Ulcerative Colitis and Crohn�s Disease), By Route of Administration (Oral and Injectables), By Drug Class (IL Inhibitors, TNF Inhibitors, Anti-integrin, JAK Inhibitors, Corticosteroids, ASA Drugs, and Others), By Distribution Channel (Hospital Pharmacy and Retail Pharmacy & Other), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106704

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Crohn’s Disease, By Key Regions/Countries, 2023
    2. Prevalence of Ulcerative Colitis, By Key Regions/Countries, 2023
    3. Average Length of Therapy for Inflammatory Bowel Disease
    4. Statistical Overview of Patients Undergoing Different Therapies
    5. Pricing and Margin Analysis
    6. New Product Launches, By Key Players
    7. Key Industry Developments – Mergers, Acquisitions, and Partnerships
    8. Pipeline Analysis, By Key Players
    9. COVID-19 Impact on the Market
  5. Global Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn’s Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn’s Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Disease Indication
      2. Canada
        1. By Disease Indication
  7. Europe Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn’s Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Disease Indication
      2. Germany
        1. By Disease Indication
      3. France
        1. By Disease Indication
      4. Spain
        1. By Disease Indication
      5. Italy
        1. By Disease Indication
      6. Scandinavia
        1. By Disease Indication
      7. Rest of Europe
        1. By Disease Indication
  8. Asia Pacific Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn’s Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Disease Indication
      2. China
        1. By Disease Indication
      3. India
        1. By Disease Indication
      4. Australia
        1. By Disease Indication
      5. Southeast Asia
        1. By Disease Indication
      6. Rest of Asia Pacific
        1. By Disease Indication
  9. Latin America Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn’s Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Disease Indication
      2. Mexico
        1. By Disease Indication
      3. Rest of Latin America
        1. By Disease Indication
  10. Middle East & Africa Inflammatory Bowel Disease Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Ulcerative Colitis
      2. Crohn’s Disease
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectables
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. IL Inhibitors
      2. TNF Inhibitors
      3. Anti-integrin
      4. JAK Inhibitors
      5. Corticosteroids
      6. ASA Drugs
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC Countries
        1. By Disease Indication
      2. South Africa
        1. By Disease Indication
      3. Rest of Middle East & Africa
        1. By Disease Indication
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. CELLTRION INC.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. AbbVie Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. UCB S.A.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Bausch Health Companies Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Bristol-Myers Squibb Company
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Eli Lilly and Company
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Gilead Sciences
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. EA Pharma Co., Ltd
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Inflammatory Bowel Disease Treatment Market Revenue Breakdown (USD billion, %) By Region, 2023 & 2032

Figure 2: Global Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2023 & 2032

Figure 3: Global Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2023 & 2032

Figure 4: Global Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2023 & 2032

Figure 5: Global Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2023 & 2032

Figure 6: Global Inflammatory Bowel Disease Treatment Market Value (USD billion), By Region, 2023 & 2032

Figure 7: North America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Disease Indication, 2023 & 2032

Figure 8: North America Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2023

Figure 9: North America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Route of Administration, 2023 & 2032

Figure 10: North America Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2023

Figure 11: North America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Drug Class, 2023 & 2032

Figure 12: North America Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2023

Figure 13: North America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 14: North America Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2023

Figure 15: North America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Inflammatory Bowel Disease Treatment Market Value Share (%), By Country, 2023

Figure 17: Europe Inflammatory Bowel Disease Treatment Market Value (USD billion), By Disease Indication, 2023 & 2032

Figure 18: Europe Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2023

Figure 19: Europe Inflammatory Bowel Disease Treatment Market Value (USD billion), By Route of Administration, 2023 & 2032

Figure 20: Europe Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2023

Figure 21: Europe Inflammatory Bowel Disease Treatment Market Value (USD billion), By Drug Class, 2023 & 2032

Figure 22: Europe Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2023

Figure 23: Europe Inflammatory Bowel Disease Treatment Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 24: Europe Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2023

Figure 25: Europe Inflammatory Bowel Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Inflammatory Bowel Disease Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Inflammatory Bowel Disease Treatment Market Value (USD billion), By Disease Indication, 2023 & 2032

Figure 28: Asia Pacific Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2023

Figure 29: Asia Pacific Inflammatory Bowel Disease Treatment Market Value (USD billion), By Route of Administration, 2023 & 2032

Figure 30: Asia Pacific Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2023

Figure 31: Asia Pacific Inflammatory Bowel Disease Treatment Market Value (USD billion), By Drug Class, 2023 & 2032

Figure 32: Asia Pacific Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2023

Figure 33: Asia Pacific Inflammatory Bowel Disease Treatment Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 34: Asia Pacific Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2023

Figure 35: Asia Pacific Inflammatory Bowel Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Inflammatory Bowel Disease Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Disease Indication, 2023 & 2032

Figure 38: Latin America Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2023

Figure 39: Latin America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Route of Administration, 2023 & 2032

Figure 40: Latin America Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2023

Figure 41: Latin America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Drug Class, 2023 & 2032

Figure 42: Latin America Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2023

Figure 43: Latin America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 44: Latin America Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2023

Figure 45: Latin America Inflammatory Bowel Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Inflammatory Bowel Disease Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value (USD billion), By Disease Indication, 2023 & 2032

Figure 48: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value Share (%), By Disease Indication, 2023

Figure 49: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value (USD billion), By Route of Administration, 2023 & 2032

Figure 50: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value Share (%), By Route of Administration, 2023

Figure 51: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value (USD billion), By Drug Class, 2023 & 2032

Figure 52: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value Share (%), By Drug Class, 2023

Figure 53: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 54: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value Share (%), By Distribution Channel, 2023

Figure 55: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 56: Middle East & Africa Inflammatory Bowel Disease Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Inflammatory Bowel Disease Treatment Market Share (%), By Company, 2023

Table 1: Global Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 2: Global Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032

Table 3: Global Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 4: Global Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 5: Global Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 6: North America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 7: North America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032

Table 8: North America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 9: North America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 10: North America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: U.S. Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 12: Canada Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 13: Europe Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 14: Europe Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032

Table 15: Europe Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 16: Europe Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 17: Europe Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 18: Germany Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 19: U.K. Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 20: France Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 21: Italy Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 22: Spain Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 23: Scandinavia Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 24: Rest of Europe Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 25: Asia Pacific Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 26: Asia Pacific Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032

Table 27: Asia Pacific Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 28: Asia Pacific Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 29: Asia Pacific Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 30: Japan Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 31: India Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 32: China Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 33: Australia Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 34: Southeast Asia Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 35: Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 36: Latin America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 37: Latin America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032

Table 38: Latin America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 39: Latin America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 40: Latin America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 41: Brazil Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 42: Mexico Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 43: Rest of Latin America Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 44: Middle East & Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 45: Middle East & Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032

Table 46: Middle East & Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 47: Middle East & Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 48: Middle East & Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 49: GCC Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 50: South Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Table 51: Rest of Middle East & Africa Inflammatory Bowel Disease Treatment Market Revenue (USD billion) Forecast, By Disease Indication, 2019-2032

Inflammatory Bowel Disease Treatment Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 181
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase